Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia

Journal of Psychiatric Research

Volumn 60, Issue , 2015, Pages 109-116

  Ansoleaga, Belén ^a   Garcia Esparcia, Paula ^a   Pinacho, Raquel ^b,c   Haro, Josep Maria ^b,c   Ramos, Belén ^b,c   Ferrer, Isidre ^a,b,d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Antipsychotics; Olfactory receptors; Prefrontal cortex; Schizophrenia; Taste receptors

Indexed keywords

CHLORPROMAZINE; DOPAMINE RECEPTOR BLOCKING AGENT; G PROTEIN COUPLED RECEPTOR; NEUROLEPTIC AGENT; OLFACTORY RECEPTOR; TASTE RECEPTORS, TYPE 2;

AGED; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HEBEPHRENIA; HUMAN; HUMAN TISSUE; MALE; NEGATIVE SYNDROME; OLFACTORY RECEPTOR; OR10G8 GENE; OR2D2 GENE; OR2T1 GENE; OR2T33 GENE; OR51E1 GENE; OR52H1 GENE; OR52L1 GENE; PARANOID SCHIZOPHRENIA; POLYMERASE CHAIN REACTION; POSITIVE AND NEGATIVE SYNDROME SCALE; PREFRONTAL CORTEX; RESIDUAL SCHIZOPHRENIA; SCHIZOPHRENIA; SIMPLE SCHIZOPHRENIA; TASTE BUD; CASE CONTROL STUDY; CHRONIC DISEASE; DRUG EFFECTS; GENETICS; METABOLISM; POSTMORTEM CHANGE; PSYCHOLOGICAL RATING SCALE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CHLORPROMAZINE; CHRONIC DISEASE; DOPAMINE ANTAGONISTS; DOWN-REGULATION; HUMANS; MALE; POLYMERASE CHAIN REACTION; POSTMORTEM CHANGES; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, ODORANT; SCHIZOPHRENIA;

EID: 84918801398     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.09.012     Document Type: Article

References (90)

1. Adler E., Hoon M.A., Mueller K.L., Chandrashekar J., Ryba N.J., Zuker C.S. Anovel family of mammalian taste receptors. Cell 2000, 100:693-702.
2. Aggio J.F., Tieu R., Wei A., Derby C.D. Oesophageal chemoreceptors of blue crabs, Callinectes sapidus, sense chemical deterrents and can block ingestion of food. JExp Biol 2012, 215:1700-1710.
3. Amador X.F., Kirkpatrick B., Buchanan R.W., Carpenter W.T., Marcinko L., Yale S.A. Stability of the diagnosis of deficit syndrome in schizophrenia. Am J Psychiatry 1999, 156:637-639.
4. Ansoleaga B., Garcia-Esparcia P., Llorens F., Moreno J., Aso E., Ferrer I. Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience 2013, 248C:369-382.
5. Aoyama Y., Mouri A., Toriumi K., Koseki T., Narusawa S., Ikawa N., et al. Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor. Int J Neuropsychopharmacol 2014, 17:723-737.
6. Arndt S., Andreasen N.C., Flaum M., Miller D., Nopoulos P. Alongitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry 1995, 52:352-360.
7. Attems J., Walker L., Jellinger K.A. Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol 2014, 127:459-475.
8. Auster T.L., Cohen A.S., Callaway D.A., Brown L.A. Objective and subjective olfaction across the schizophrenia spectrum. Psychiatry 2014, 77:57-66.
9. Barnea G., O'Donnell S., Mancia F., Sun X., Nemes A., Mendelsohn M., et al. Odorant receptors on axon termini in the brain. Science 2004, 304:1468.
10. Behrens M., Meyerhof W. Oral and extraoral bitter taste receptors. Results Probl Cell Differ 2010, 52:87-99.
11. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JRoy Stat Soc Ser B 1995, 57:289-300.
12. Borde M., Davis E.J., Sharma L.N. The stability of symptoms and syndromes in chronic schizophrenic patients. Indian J Psychiatry 1992, 34:133-139.
13. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006, 112:389-404.
14. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
15. Branscomb A., Seger J., White R.L. Evolution of odorant receptors expressed in mammalian testes. Genetics 2000, 156:785-797.
16. Brewer W.J., Pantelis C. Olfactory sensitivity: functioning in schizophrenia and implications for understanding the nature and progression of psychosis. Vitam Horm 2010, 83:305-329.
17. Brewer W.J., Pantelis C., Anderson V., Velakoulis D., Singh B., Copolov D.L., et al. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am J Psychiatry 2001, 158:107-115.
18. Clark C., Kopala L., Hurwitz T., Li D. Regional metabolism in microsmic patients with schizophrenia. Can J Psychiatry 1991, 36:645-650.
19. Cohen A.S., Brown L.A., Auster T.L. Olfaction, "olfiction," and the schizophrenia-spectrum: an updated meta-analysis on identification and acuity. Schizophr Res 2012, 135:152-157.
20. Compton M.T., Chien V.H., Bollini A.M., Walker E.F. Lack of support for the inability to taste phenylthiocarbamide as an endophenotypic marker in patients with schizophrenia and their first-degree relatives. Schizophr Res 2007, 95:65-69.
21. Compton M.T., Ionescu D.F., Broussard B., Cristofaro S.L., Johnson S., Haggard P.J., et al. An examination of associations between the inability to taste phenylthiocarbamide (PTC) and clinical characteristics and trait markers in first-episode, nonaffective psychotic disorders. Psychiatry Res 2013, 209:27-31.
22. De la Cruz O., Blekhman R., Zhang X., Nicolae D., Firestein S., Gilad Y. Asignature of evolutionary constraint on a subset of ectopically expressed olfactory receptor genes. Mol Biol Evol 2009, 26:491-494.
23. Dehkordi O., Rose J.E., Fatemi M., Allard J.S., Balan K.V., Young J.K., et al. Neuronal expression of bitter taste receptors and downstream signaling molecules in the rat brainstem. Brain Res 2012, 1475:1-10.
24. Deshpande D.A., Wang W.C., McIlmoyle E.L., Robinett K.S., Schillinger R.M., An S.S., et al. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 2010, 16:1299-1304.
25. Doty R. Handbook of olfaction and gustation 2003.
26. Doty R.L. Olfaction in Parkinson's disease and related disorders. Neurobiol Dis 2012, 46:527-552.
27. Dreyer W.J. The area code hypothesis revisited: olfactory receptors and other related transmembrane receptors may function as the last digits in a cell surface code for assembling embryos. Proc Natl Acad Sci U S A 1998, 95:9072-9077.
28. English J.A., Pennington K., Dunn M.J., Cotter D.R. The neuroproteomics of schizophrenia. Biol Psychiatry 2011, 69:163-172.
29. Feinstein P., Bozza T., Rodriguez I., Vassalli A., Mombaerts P. Axon guidance of mouse olfactory sensory neurons by odorant receptors and the beta2 adrenergic receptor. Cell 2004, 117:833-846.
30. Feinstein P., Mombaerts P. Acontextual model for axonal sorting into glomeruli in the mouse olfactory system. Cell 2004, 117:817-831.
31. Feldmesser E., Olender T., Khen M., Yanai I., Ophir R., Lancet D. Widespread ectopic expression of olfactory receptor genes. BMC Genomics 2006, 7:121.
32. Frith C., Dolan R. The role of the prefrontal cortex in higher cognitive functions. Brain Res Cogn Brain Res 1996, 5:175-181.
33. Fukuda N., Yomogida K., Okabe M., Touhara K. Functional characterization of a mouse testicular olfactory receptor and its role in chemosensing and in regulation of sperm motility. JCell Sci 2004, 117:5835-5845.
34. Garcia-Esparcia P., Schluter A., Carmona M., Moreno J., Ansoleaga B., Torrejon-Escribano B., et al. Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. JNeuropathol Exp Neurol 2013, 72:524-539.
35. Gardner D.M., Murphy A.L., O'Donnell H., Centorrino F., Baldessarini R.J. International consensus study of antipsychotic dosing. Am J Psychiatry 2010, 167:686-693.
36. Glusman G., Yanai I., Rubin I., Lancet D. The complete human olfactory subgenome. Genome Res 2001, 11:685-702.
37. Gold J.M. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 2004, 72:21-28.
38. Goldstein J.M., Goodman J.M., Seidman L.J., Kennedy D.N., Makris N., Lee H., et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 1999, 56:537-547.
39. Griffin C.A., Kafadar K.A., Pavlath G.K. MOR23 promotes muscle regeneration and regulates cell adhesion and migration. Dev Cell 2009, 17:649-661.
40. Grison A., Zucchelli S., Urzì A., Zamparo I., Lazarevic D., Pascarella G., et al. Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules. BMC Genomics 2014, 15:729.
41. Haro J.M., Kamath S.A., Ochoa S., Novick D., Rele K., Fargas A., et al. The clinical global impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl 2003, 16-23.
42. Hoppe R., Frank H., Breer H., Strotmann J. The clustered olfactory receptor gene family 262: genomic organization, promotor elements, and interacting transcription factors. Genome Res 2003, 13:2674-2685.
43. Kang N., Koo J. Olfactory receptors in non-chemosensory tissues. BMB Rep 2012, 45:612-622.
44. Kantrowitz J.T., Javitt D.C. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?. Brain Res Bull 2010, 83:108-121.
45. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
46. Kayser J., Tenke C.E., Kroppmann C.J., Alschuler D.M., Ben-David S., Fekri S., et al. Olfaction in the psychosis prodrome: electrophysiological and behavioral measures of odor detection. Int J Psychophysiol 2013, 90:190-206.
47. Kienast T., Heinz A. Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 2006, 5:109-131.
48. Kinnamon S.C. Taste receptor signalling - from tongues to lungs. Acta Physiol (Oxf) 2012, 204:158-168.
49. Konradi C. Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Brain Res Brain Res Rev 2005, 50:142-155.
50. Kopala L.C., Good K.P., Honer W.G. Olfactory hallucinations and olfactory identification ability in patients with schizophrenia and other psychiatric disorders. Schizophr Res 1994, 12:205-211.
51. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994, 51:199-214.
52. Kurita M., Holloway T., García-Bea A., Kozlenkov A., Friedman A.K., Moreno J.L., et al. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci 2012, 15:1245-1254.
53. Le Danvic C., Guiraudie-Capraz G., Abderrahmani D., Zanetta J.P., Nagnan-Le Meillour P. Natural ligands of porcine olfactory binding proteins. JChem Ecol 2009, 35:741-751.
54. Lewis D.A., Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 2006, 63:1372-1376.
55. Li F. Taste perception: from the tongue to the testis. Mol Hum Reprod 2013, 19:349-360.
56. Malaspina D., Perera G.M., Lignelli A., Marshall R.S., Esser P.D., Storer S., et al. SPECT imaging of odor identification in schizophrenia. Psychiatry Res 1998, 82:53-61.
57. Malnic B., Godfrey P.A., Buck L.B. The human olfactory receptor gene family. Proc Natl Acad Sci U S A 2004, 101:2584-2589.
58. Moberg P.J., Agrin R., Gur R.E., Gur R.C., Turetsky B.I., Doty R.L. Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology 1999, 21:325-340.
59. Moberg P.J., Arnold S.E., Doty R.L., Gur R.E., Balderston C.C., Roalf D.R., et al. Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. JClin Exp Neuropsychol 2006, 28:1444-1461.
60. Moberg P.J., Li M., Kanes S.J., Gur R.E., Kamath V., Turetsky B.I. Association of schizophrenia with the phenylthiocarbamide taste receptor haplotype on chromosome 7q. Psychiatr Genet 2012, 22:286-289.
61. Moberg P.J., McGue C., Kanes S.J., Roalf D.R., Balderston C.C., Gur R.E., et al. Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance. Schizophr Res 2007, 90:221-228.
62. Nguyen A.D., Pelavin P.E., Shenton M.E., Chilakamarri P., McCarley R.W., Nestor P.G., et al. Olfactory sulcal depth and olfactory bulb volume in patients with schizophrenia: an MRI study. Brain Imaging Behav 2011, 5:252-261.
63. Nguyen A.D., Shenton M.E., Levitt J.J. Olfactory dysfunction in schizophrenia: a review of neuroanatomy and psychophysiological measurements. Harv Rev Psychiatry 2010, 18:279-292.
64. Niimura Y., Nei M. Comparative evolutionary analysis of olfactory receptor gene clusters between humans and mice. Gene 2005, 346:13-21.
65. Otaki J.M., Yamamoto H., Firestein S. Odorant receptor expression in the mouse cerebral cortex. JNeurobiol 2004, 58:315-327.
66. Parmentier M., Libert F., Schurmans S., Schiffmann S., Lefort A., Eggerickx D., et al. Expression of members of the putative olfactory receptor gene family in mammalian germ cells. Nature 1992, 355:453-455.
67. Reichenberg A., Rieckmann N., Harvey P.D. Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim psychiatric center longitudinal Study. JAbnorm Psychol 2005, 114:363-372.
68. Rey E.R., Bailer J., Brauer W., Handel M., Laubenstein D., Stein A. Stability trends and longitudinal correlations of negative and positive syndromes within a three-year follow-up of initially hospitalized schizophrenics. Acta Psychiatr Scand 1994, 90:405-412.
69. Roca M., Escanilla A., Monje A., Baño V., Planchat L., Costa J., et al. Banco de tejidos neurológicos de Sant Joan de Déu-Serveis de Salut Mental para la investigación de las enfermedades mentales. La importancia de un programa de donación en vida. Psiquiatr Biológica 2008, 15:73-79.
70. Rupp C.I. Olfactory function and schizophrenia: an update. Curr Opin Psychiatry 2010, 23:97-102.
71. Schneider F., Habel U., Reske M., Toni I., Falkai P., Shah N.J. Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives. Psychiatry Res 2007, 155:103-112.
72. Semkovska M., Bedard M.A., Stip E. Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives. Encephale 2001, 27:405-415.
73. Singh N., Vrontakis M., Parkinson F., Chelikani P. Functional bitter taste receptors are expressed in brain cells. Biochem Biophys Res Commun 2011, 406:146-151.
74. Spehr M., Gisselmann G., Poplawski A., Riffell J.A., Wetzel C.H., Zimmer R.K., et al. Identification of a testicular odorant receptor mediating human sperm chemotaxis. Science 2003, 299:2054-2058.
75. Spehr M., Schwane K., Heilmann S., Gisselmann G., Hummel T., Hatt H. Dual capacity of a human olfactory receptor. Curr Biol 2004, 14:R832-R833.
76. Stahl S.M., Buckley P.F. Negative symptoms of schizophrenia: a problem that will not go away. Acta Psychiatr Scand 2007, 115:4-11.
77. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008, 102:1-18.
78. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res 2009, 110:1-23.
79. Teffer K., Semendeferi K. Human prefrontal cortex: evolution, development, and pathology. Prog Brain Res 2012, 195:191-218.
80. Toda M., Abi-Dargham A. Dopamine hypothesis of schizophrenia: making sense of it all. Curr Psychiatry Rep 2007, 9:329-336.
81. Turetsky B.I., Hahn C.G., Arnold S.E., Moberg P.J. Olfactory receptor neuron dysfunction in schizophrenia. Neuropsychopharmacology 2009, 34:767-774.
82. Vanderhaeghen P., Schurmans S., Vassart G., Parmentier M. Molecular cloning and chromosomal mapping of olfactory receptor genes expressed in the male germ line: evidence for their wide distribution in the human genome. Biochem Biophys Res Commun 1997, 237:283-287.
83. Weber M., Pehl U., Breer H., Strotmann J. Olfactory receptor expressed in ganglia of the autonomic nervous system. JNeurosci Res 2002, 68:176-184.
84. Wetzel C.H., Oles M., Wellerdieck C., Kuczkowiak M., Gisselmann G., Hatt H. Specificity and sensitivity of a human olfactory receptor functionally expressed in human embryonic kidney 293 cells and Xenopus Laevis oocytes. JNeurosci 1999, 19:7426-7433.
85. Wong A.H., Van Tol H.H. Schizophrenia: from phenomenology to neurobiology. Neurosci Biobehav Rev 2003, 27:269-306.
86. Wu J., Buchsbaum M.S., Moy K., Denlea N., Kesslak P., Tseng H., et al. Olfactory memory in unmedicated schizophrenics. Schizophr Res 1993, 9:41-47.
87. Xu J., Cao J., Iguchi N., Riethmacher D., Huang L. Functional characterization of bitter-taste receptors expressed in mammalian testis. Mol Hum Reprod 2013, 19:17-28.
88. Yamamoto K., Ishimaru Y. Oral and extra-oral taste perception. Semin Cell Dev Biol 2013, 24:240-246.
89. Zhang X., De la Cruz O., Pinto J.M., Nicolae D., Firestein S., Gilad Y. Characterizing the expression of the human olfactory receptor gene family using a novel DNA microarray. Genome Biol 2007, 8:R86.
90. Zozulya S., Echeverri F., Nguyen T. The human olfactory receptor repertoire. Genome Biol 2001, 2. RESEARCH0018.